vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $22.7M, roughly 1.9× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -227.5%, a 228.2% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs 14.0%). R F INDUSTRIES LTD produced more free cash flow last quarter ($2.0M vs $-63.9M). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs 27.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
GRAL vs RFIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $22.7M |
| Net Profit | $-99.2M | $173.0K |
| Gross Margin | — | 36.8% |
| Operating Margin | -285.4% | 4.0% |
| Net Margin | -227.5% | 0.8% |
| Revenue YoY | 14.0% | 22.9% |
| Net Profit YoY | -2.2% | 172.7% |
| EPS (diluted) | $-2.37 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $22.7M | ||
| Q3 25 | $36.2M | $19.8M | ||
| Q2 25 | $35.5M | $18.9M | ||
| Q1 25 | $31.8M | $19.2M | ||
| Q4 24 | $38.3M | $18.5M | ||
| Q3 24 | $28.7M | $16.8M | ||
| Q2 24 | $32.0M | $16.1M | ||
| Q1 24 | $26.7M | $13.5M |
| Q4 25 | $-99.2M | $173.0K | ||
| Q3 25 | $-89.0M | $392.0K | ||
| Q2 25 | $-114.0M | $-245.0K | ||
| Q1 25 | $-106.2M | $-245.0K | ||
| Q4 24 | $-97.1M | $-238.0K | ||
| Q3 24 | $-125.7M | $-705.0K | ||
| Q2 24 | $-1.6B | $-4.3M | ||
| Q1 24 | $-218.9M | $-1.4M |
| Q4 25 | — | 36.8% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 29.8% | ||
| Q4 24 | — | 31.3% | ||
| Q3 24 | — | 29.5% | ||
| Q2 24 | — | 29.9% | ||
| Q1 24 | — | 24.5% |
| Q4 25 | -285.4% | 4.0% | ||
| Q3 25 | -346.2% | 3.6% | ||
| Q2 25 | -446.9% | 0.6% | ||
| Q1 25 | -482.5% | 0.3% | ||
| Q4 24 | -358.0% | 0.5% | ||
| Q3 24 | -640.5% | -2.5% | ||
| Q2 24 | -5133.8% | -2.6% | ||
| Q1 24 | -851.1% | -15.5% |
| Q4 25 | -227.5% | 0.8% | ||
| Q3 25 | -245.8% | 2.0% | ||
| Q2 25 | -320.7% | -1.3% | ||
| Q1 25 | -333.6% | -1.3% | ||
| Q4 24 | -253.8% | -1.3% | ||
| Q3 24 | -438.7% | -4.2% | ||
| Q2 24 | -4958.8% | -26.7% | ||
| Q1 24 | -819.3% | -10.1% |
| Q4 25 | $-2.37 | $0.01 | ||
| Q3 25 | $-2.46 | $0.04 | ||
| Q2 25 | $-3.18 | $-0.02 | ||
| Q1 25 | $-3.10 | $-0.02 | ||
| Q4 24 | $-1.49 | $-0.02 | ||
| Q3 24 | $-3.94 | $-0.07 | ||
| Q2 24 | $-51.06 | $-0.41 | ||
| Q1 24 | $-7.05 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $35.2M |
| Total Assets | $2.9B | $73.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $5.1M | ||
| Q3 25 | $126.9M | $3.0M | ||
| Q2 25 | $127.4M | $3.6M | ||
| Q1 25 | $133.9M | $1.3M | ||
| Q4 24 | $214.2M | $839.0K | ||
| Q3 24 | $853.6M | $1.8M | ||
| Q2 24 | $958.8M | $1.4M | ||
| Q1 24 | $199.7M | $4.5M |
| Q4 25 | $2.6B | $35.2M | ||
| Q3 25 | $2.2B | $34.8M | ||
| Q2 25 | $2.3B | $34.2M | ||
| Q1 25 | $2.4B | $34.2M | ||
| Q4 24 | $2.5B | $34.1M | ||
| Q3 24 | $2.6B | $34.1M | ||
| Q2 24 | $2.7B | $34.6M | ||
| Q1 24 | — | $38.7M |
| Q4 25 | $2.9B | $73.0M | ||
| Q3 25 | $2.6B | $73.2M | ||
| Q2 25 | $2.7B | $72.7M | ||
| Q1 25 | $2.8B | $70.4M | ||
| Q4 24 | $3.0B | $71.0M | ||
| Q3 24 | $3.1B | $71.9M | ||
| Q2 24 | $3.3B | $72.8M | ||
| Q1 24 | — | $79.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $2.1M |
| Free Cash FlowOCF − Capex | $-63.9M | $2.0M |
| FCF MarginFCF / Revenue | -146.5% | 9.0% |
| Capex IntensityCapex / Revenue | 0.2% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 12.13× |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $4.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $2.1M | ||
| Q3 25 | $-63.2M | $-311.0K | ||
| Q2 25 | $-77.0M | $2.2M | ||
| Q1 25 | $-95.0M | $601.0K | ||
| Q4 24 | — | $-244.0K | ||
| Q3 24 | $-104.6M | $2.4M | ||
| Q2 24 | $-171.8M | $197.0K | ||
| Q1 24 | $-207.3M | $840.0K |
| Q4 25 | $-63.9M | $2.0M | ||
| Q3 25 | $-63.6M | $-419.0K | ||
| Q2 25 | $-77.3M | $2.2M | ||
| Q1 25 | $-95.1M | $574.0K | ||
| Q4 24 | — | $-418.0K | ||
| Q3 24 | $-105.6M | $2.1M | ||
| Q2 24 | $-173.2M | $28.0K | ||
| Q1 24 | $-209.8M | $697.0K |
| Q4 25 | -146.5% | 9.0% | ||
| Q3 25 | -175.8% | -2.1% | ||
| Q2 25 | -217.6% | 11.4% | ||
| Q1 25 | -298.6% | 3.0% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | -368.4% | 12.6% | ||
| Q2 24 | -541.7% | 0.2% | ||
| Q1 24 | -785.3% | 5.2% |
| Q4 25 | 0.2% | 0.3% | ||
| Q3 25 | 1.1% | 0.5% | ||
| Q2 25 | 1.0% | 0.2% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | 3.4% | 1.5% | ||
| Q2 24 | 4.3% | 1.0% | ||
| Q1 24 | 9.5% | 1.1% |
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |
